Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04533958Not ApplicableRecruiting

Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy

Role: lead

NCT06199115Not ApplicableUnknown

Prevention of Neuropathic Pain From Oxaliplatin by Photobiomodulation

Role: lead

NCT05149105Not ApplicableUnknown

Efficiency of Using Argon Plasma Coagulation in Weight Regain in Patients Following Gastric Bypass

Role: lead

NCT04470232Unknown

Transcultural and Psychometric Validation of SUSHI and HOOS-12 Scores in Patients With Coxofemoral Pathologies

Role: collaborator

NCT02971852Completed

Effects of Hypnosis on Skin Temperature

Role: collaborator

All 5 trials loaded